enVVeno Medical Corporation
Price
FilingsNewest: S-3, Shelf registrationAug 21 →InsidersNo open-market buys. 1 insider sold $4,944, all 4 sales on a 10b5-1 plan.→HoldersKingdon 5.4%CM 5.3%Vanguard 0.9%→Financing →PeersClosest companies: NRXS, BBLG, RKTO→
From the filings
Figures
- Net income
- −$15.7Mlast 12 months
- Operating cash flow
- −$14.8Mlast 12 months
- Cash and equivalents
- $2.8Mat the last balance sheet
- Shares outstanding
- 673.0K shareson issue